Press Releases COGNOA PRESS RELEASES ECHO Autism Communities Collaborate with Cognoa to Study Real-World Application of Canvas Dx Read More » June 1, 2022 Cognoa Announces Nature Digital Medicine Publication of Pivotal Study Results Showing the Effectiveness of its Digital Diagnostic Device for Autism Read More » May 5, 2022 Cognoa to Present and Exhibit at the 2022 American Academy of Neurology (AAN) Annual Meeting Read More » April 4, 2022 Cognoa Named One Of Fierce Medtech’s 2022 Fierce 15 Read More » March 7, 2022 Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer Read More » September 30, 2021 Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid Read More » June 2, 2021 « Previous Page1 Page2 Page3 Page4 Page5 Next » For media inquiries, please contact media@cognoa.com Learn about our efforts to advance pediatric behavioral healthcare. Learn More
ECHO Autism Communities Collaborate with Cognoa to Study Real-World Application of Canvas Dx Read More » June 1, 2022
Cognoa Announces Nature Digital Medicine Publication of Pivotal Study Results Showing the Effectiveness of its Digital Diagnostic Device for Autism Read More » May 5, 2022
Cognoa to Present and Exhibit at the 2022 American Academy of Neurology (AAN) Annual Meeting Read More » April 4, 2022
Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer Read More » September 30, 2021
Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid Read More » June 2, 2021
